Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q1 FY24 results · Apr–Jun 2023
Caplin Point Laboratories reported revenue from operations of ₹395.32 crore (up 14.1% from Q1 FY23) and net profit of ₹104.23 crore (up 20.8% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 395.32 | 346.33 | +14.1% | 389.28 | +1.6% |
| Other income | 12.04 | 13.94 | −13.6% | 11.40 | +5.6% |
| Total income | 407.36 | 360.27 | +13.1% | 400.68 | +1.7% |
| Profit before tax | 126.99 | 105.09 | +20.8% | 124.05 | +2.4% |
| Net profit for the period | 104.23 | 86.31 | +20.8% | 101.24 | +3.0% |
| Attributable to shareholders of the company | 103.43 | 84.99 | +21.7% | 102.11 | +1.3% |
| EPS, basic (₹) | 13.62 | 11.21 | +21.5% | 13.45 | +1.3% |
| Net margin (%) | 26.4 | 24.9 | 26.0 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 173.66 | 116.39 | +49.2% | 144.67 | +20.0% |
| Other income | 27.27 | 34.97 | −22.0% | 12.22 | +123.2% |
| Total income | 200.93 | 151.36 | +32.7% | 156.89 | +28.1% |
| Profit before tax | 97.19 | 74.70 | +30.1% | 70.77 | +37.3% |
| Net profit for the period | 76.27 | 63.24 | +20.6% | 54.33 | +40.4% |
| EPS, basic (₹) | 10.04 | 8.34 | +20.4% | 7.15 | +40.4% |
| Net margin (%) | 43.9 | 54.3 | 37.6 |
Consolidated
- Filed with BSE
- 08 Aug 2023, 13:27 IST
- Board meeting
- 07 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Aug 2023, 13:27 IST
- Board meeting
- 07 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE